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Abstract 
Background: Microscopy and rapid diagnosis tests have a limited sensitivity in diagnosis of malaria by Plasmodium 
ovale. The LAMP kit (LoopAMP®) can be used in the field without special equipment and could have an important role 
in malaria control programmes in endemic areas and for malaria diagnosis in returned travellers. The performance of 
the Pan primer of the kit in detecting malaria by P. ovale was compared with the results of standard nPCR in samples 
of patients returning from P. ovale endemic areas.
Methods: Plasmodium ovale positive samples (29, tested by PCR and/or microscopy) and malaria negative specimens 
(398, tested by microscopy and PCR) were collected in different hospitals of Europe from June 2014 to March 2016 
and frozen at −20 °C. Boil and spin method was used to extract DNA from all samples and amplification was per‑
formed with LoopAMP® MALARIA kit (Eiken Chemical, Japan) in an automated turbidimeter (Eiken 500). The results of 
LAMP read by turbidimetry and with the naked eye were compared.
Results: The kit showed a sensitivity of 100% and a specificity of 97.24% with positive and negative predictive values 
of 72.5 and 100%, respectively. Naked eyed readings were in accordance with turbidimetry readings (sensitivity, 92.5%, 
specificity, 98.96% and positive and negative predictive values, respectively, 90.24 and 99.22%). The limit of detection 
of LAMP assay for P. ovale was between 0.8 and 2 parasites/µl.
Conclusions: The Pan primer of the Malaria kit LoopAMP® can detect P. ovale at very low‑levels and showed a predic‑
tive negative value of 100%. This tool can be useful in malaria control and elimination programmes and in returned 
travellers from P. ovale endemic areas. Naked eye readings are equivalent to automated turbidimeter readings in speci‑
mens obtained with EDTA.
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Background
Malaria incidence has recently been declining globally, 
although in many African countries it is still one of the 
top health problems. The efforts to control and eradi-
cate malaria will still need a strong diagnostic capacity, 
which allows any parasitaemic patient to be detected and 
treated sooner. LAMP is a simple molecular diagnostic 
method based on the principle of isothermal amplifica-
tion, which does not require special equipment or special 
distribution in laboratories, and provide results in 60 min 
[1]. Different clinical studies have validated this rapid 
molecular test in the field with a performance similar to 
conventional PCR [2, 3]. Additional advantages of LAMP 
are its tolerance to inhibitory substances present in blood 
samples (such as haemoglobin and immunoglobulin) [4] 
and the possibility of being used also on small amounts of 
blood on filter papers. Furthermore, it could be combined 
with simple techniques such as microwave DNA extrac-
tion [5] in basic laboratories in low resource settings. 
On the other hand, the growth in international travel 
and migration has increased the incidence of imported 
malaria cases in developed countries. In Spain, submi-
croscopic malaria is common in sub-Saharan migrants 
(up to 35.5% in one series [6]) and Plasmodium ovale 
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infection may represent up to 8% of imported malaria 
cases, as shown in some published series of mainly West 
African patients [7]. Therefore, sensitive molecular tools 
are needed both for malaria control programmes and 
for detecting with certainty malaria imported cases in 
patients returning from P. ovale endemic areas.
LAMP has showed excellent sensitivity and specificity 
in diagnosing Plasmodium falciparum and Plasmodium 
vivax malaria, but there is little information about the 
performance of the test for other species, such as Plas-
modium malariae, P. ovale and Plasmodium knowlesi. 
Although no specific P. ovale LAMP primers is commer-
cially available, the PAN primer of the LoopAMP® test 
could be used for initial detection of P. ovale infections.
The primary objective of this study was to determine 
the diagnostic validity of LoopAMP® in comparison 
to microscopy and conventional multiplex nested PCR 
(nPCR) in the diagnosis of P. ovale infections in archived 
clinical specimens. Secondary objectives were to com-
pare the naked eye reading of the amplification products 
with the automated reading by turbidimetry as well as to 
determine the specificity of the P. falciparum LoopAmp® 
primer in specimens of patients infected with P. ovale.
Methods
The study protocol was previously approved by the Ethics 
Committee of the Hospital Príncipe de Asturias, Madrid, 
Spain. Signed informed consents were obtained from all 
individuals with P. ovale malaria from whom blood sam-
ples were collected.
Sample collection
The sample size of positive P. ovale samples was limited 
by the availability of positive specimens (n = 30; P. ovale 
wallikeri 13, P. ovale curtisi 8, unknown subspecies 9). 
These samples were collected with EDTA from venous 
blood in patients with confirmed P. ovale malaria by 
microscopy and/or PCR and then frozen at −20  °C. No 
mixed infections were included in this study. The positive 
specimens were obtained in different European hospitals 
for routine testing between June 2014 and March 2016 
in the context of an ongoing prospective clinical study 
on P. ovale infections which is being developed in Spain 
and Europe [7]. The number of negative specimens to 
be tested was established in 411, according to the preva-
lence of P. ovale imported malaria in our hospital (HUPA) 
in relation with other species (6.8%, 18 out of 263 total 
malaria cases attended in the period 2007–2015) and 
the total population studied (1.7% of 1007 patients with 
suspected malaria in the same period). These negative 
specimens were obtained from patients coming from 
West and Central Africa who attended Spanish hospitals 
with a febrile syndrome and tested negative in thick films, 
RDTs and PCR multiplex for malaria [8] and were pre-
served in the clinical specimens Archive of the Microbi-
ology Department of Hospital Príncipe de Asturias and 
in the Bio Bank of the Malaria laboratory (C.0001392) 
of the Spanish National Center for Microbiology of 
Majadahonda.
Sample processing
The boil and spin method [9] was used for extracting the 
DNA from frozen whole blood of all patients in a sample 
preparation area separated from the amplification area. 
Briefly, an aliquot of 60 μl of whole blood of each patient 
was transferred to the extraction tube and mixed with 
60 μl of extraction buffer (400 mM NaCl, 40 mM Tris pH 
6.5, 0.4% SDS) by vortex for 10 s. Extraction tubes con-
taining the samples were placed in a hot-block (Techne 
DRI-Block DB) at 95 °C for 5 min, and were subsequently 
centrifuged at 10,000g for 3  min (Jouan MR23). Finally, 
30 μl of clear supernatant were transferred to a dilution 
tube with 345 µl of sterile water (DNA samples were then 
stored at −20  °C for a maximal period of 2  months for 
testing).
LAMP reaction and reading
The commercial Pan and P. falciparum LoopAMP® kits 
(Eiken Chemical Co., ref. LMP561 and LMC562, respec-
tively) were tested with extracted DNA of blood sam-
ples collected in EDTA and kept frozen at −20 °C. Since 
EDTA can produce unspecific fluorescence under UV 
light, the readings of the amplifications products were 
performed by automated turbidimetry with a turbidim-
eter (Eiken 500) and with the naked eye [10]. Due to the 
possibility of DNA degradation with time, the archived P. 
ovale PCR positive specimens testing negative for Loo-
pAMP® were rechecked by conventional PCR to ascer-
tain DNA viability.
The Pan specific primers detect a target mitochon-
drial DNA sequence common to all the Plasmodium 
species infecting humans. From the dilution tubes, 30 μl 
of extracted DNA was added in a reaction tube for Pan 
or P. falciparum and then were shaken following the kit 
instructions for mixing and dissolving. For each batch of 
16 reactions, one amplification positive control and one 
amplification negative control were included alongside 
(14 samples and 2 controls). The Eiken 500 Turbidim-
eter was configured with the settings for malaria reaction 
(amplification at 65  °C for 40  min and enzyme inacti-
vation at 80  °C for 5  min). All the amplifications reac-
tions were also read in a blind manner with the naked 
eye for the purpose of comparison with the standard 
turbidimetry.
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Multiplex nested PCR
All samples were tested previously by a validated multi-
plex nPCR [8] and repeated, as well by duplicate, in case 
of discordance with the LAMP result. The primer used 
target the small subunit (SSU) rRNA gene and involves a 
sequence of two multiplex PCR amplifications. The first 
reaction amplifies Plasmodium ssrDNA from blood sam-
ples infected with malaria and includes a positive reac-
tion control, amplification of the Human ssrDNA gene, 
which indicates whether the reaction is working properly 
or not. The second reaction enables the identification of 
the four human malaria species (P. vivax, P. falciparum, P. 
ovale and P. malariae) for the fragment size of the prod-
uct amplified, mixed infection yield the corresponding 
fragments for species involved.
Limit of detection of the LAMP technique
The limit of detection (LoD) of the Pan primer LAMP 
assay for P. ovale was determined using two whole blood 
specimens with a known parasitaemia of P. ovale by 
microscopy (8111 and 2015 parasites/µl). Briefly, each 
sample was serially tenfold diluted down to 0.08 and 
0.02 parasites/µl, respectively, with blood from a Spanish 
patient negative for VIH, VHB, and VHC and no story of 
travelling to endemic malaria areas. DNA was extracted 
from each dilution by the boil and spin method and then 
tested by LAMP twice.
Statistical methods
Sensitivity, specificity, positive and negative predictive 
values with 95% confidence intervals (CI) were calculated 
using the nPCR as the reference test by means of EPI Dat 
(3.1) (2006) Sergas [Software] [11].
Results
A total of 427 clinical samples (29 P. ovale positive and 398 
malaria negative) were used to evaluate the performance 
of the LoopAMP malaria kit for the detection of P. ovale 
parasites in clinical samples. Of the 30 patients with P. 
ovale malaria previously confirmed by nPCR, one sample 
was excluded due to lack of amplification by LAMP as well 
as by nPCR when retested. This is possibly due to degra-
dation of DNA over time or an error in initial diagnosis. 
The other 29 samples were positive with the Pan probe 
of LAMP, obtaining a sensitivity of 100% (29/29; CI 95%: 
98.3–100%). Of the 398 negatives controls remaining after 
excluding those samples with degraded DNA and abnor-
mal curves (see Additional file 1), 11 samples were positive 
with LAMP (nPCR was repeated in these samples and was 
negative) obtaining a specificity of 97.24% (387/398; CI 
95%: 95.5–99%) compared with nPCR. Positive and nega-
tive predictive values were, respectively, 72.5% (CI 95%: 
57.4–87.6%) and 100% (CI 95%: 99.9–100%) (Table 1). 
The comparison with naked eye (NE) readings was pos-
sible in 384 LAMP negative specimens (of 387 negative 
controls only 3 were indeterminate by NE reading) and 
40 turbidimetry positive specimens (29 positive con-
trols and 11 false positive results). All in all, turbidim-
etry and NE were in good agreement, with only 4 false 
positive and 3 false negative results by NE: Sensitivity, 
92.5% [37/40; CI 95%: 83.09–100%]; Specificity, 98.96% 
[380/384 CI 95%: 98.81–100%]; positive and negative pre-
dictive values, respectively, 90.24% [CI 95%: 79.94–100%] 
and 99.22% [CI 95%: 98.20–100%] (Table 2).
Plasmodium falciparum LAMP reactions were found 
to be negative in 29 out of 29 confirmed P. ovale samples. 
One P. ovale sample positive by P. falciparum LAMP was 
excluded as it was found to be also positive for P. falcipa-
rum by nPCR. In this testing session, 8 specimens pro-
duced initially an abnormal curve (see Additional file 2) 
which was considered negative. In all these specimens 
LAMP test was repeated and a flat curve negative test 
was confirmed.
The LoD of the Pan LAMP assay for the detection of P. 
ovale parasites were determined to be at 0.8 parasites/µl 
in one of the two samples evaluated and 2 parasites/µl in 
the other one. Duplicate testing was performed with the 
same results and similar Tt in the replicates (Additional 
file 3). Then, it can be assumed a LOD of 2 parasites/µl, as 
it was the lowest value at which all replicates were posi-
tive, with a proportion of 2/4 samples detected at lower 
values (0.8 parasites/µl).
In the study, an episode of contamination during one 
of the amplification sessions was detected (unexpected 
occurrence of false positive results in some tubes in the 
Table 1 Comparison of  the Pan primer LoopAmp® 
with nested PCR (n = 427)
Sensitivity 100% (29/29; CI 95%: 98.3–100%); Specificity: 97.24% (387/398; CI 
95%: 95.5–99%). PPV and NPV, respectively, 72.5% (CI 95%: 57.4–87.6%) and 
100% (CI 95%: 99.9–100%)
LAMP positive LAMP negative
PCR positive 29 0
PCR negative 11 387
Table 2 Comparison of  reaction readings with  the naked 
eye or the turbidimeter Eiken 500
Sensitivity, 92.5% [37/40; CI 95%: 83.09–100%]; Specificity, 98.96% [380/384 CI 
95%: 98.81–100%]; PPV and NPV, respectively, 90.24% [CI 95%: 79.94–100%] and 
99.22% [CI 95%: 98.20–100%]
NE positive NE negative
Turbidimetry Pos 37 3
Turbidimetry Neg 4 381
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same day, n =  14). No apparent breaking of the proto-
cols nor incidents during pipetting procedures or leak-
ing could be detected. To solve the problem, before the 
next amplification session, all working surfaces, equip-
ments and reagents were decontaminated with sodium 
hypochlorite, a new working space for the amplification 
reaction was established, and the DNA of all false posi-
tive samples was re-extracted from archived specimens. 
The LAMP test was repeated with all these second DNA 
samples and the number of false positive results was 
reduced to 5.
Discussion
Malaria control and eradication programmes world-
wide require reliable tools for detecting very low parasite 
densities in asymptomatic patients, where microscopy 
and RDTs can produce false negative results, as it is the 
case in areas of low transmission where submicroscopic 
malaria can be a key factor in the control programmes 
[12, 13]. Non P. falciparum infections have lower para-
site densities than P. falciparum infections [12] and the 
sensitivity of RDTs in P. ovale and P. malariae infections 
can be very low [14]. On the other hand, for travellers 
returning from P. ovale endemic countries, an affordable 
molecular rapid test which no requires special equipment 
with a very high negative predictive value for all common 
species of malaria could be very useful.
In this study, it is demonstrated the accurate and sen-
sitive detection of P. ovale parasites using Plasmodium 
genus-specific LAMP assay. This is the hitherto largest 
reported study about LAMP in P. ovale malaria.
The obtained results confirm the high sensitivity and 
specificity of LAMP (100 and 97.2%, respectively) for 
detecting P. ovale infected patients with the PAN primer 
when comparing to nested PCR, as other studies showed 
previously with P. falciparum (99 and 93%) in Thailand 
[15], all five human malaria species in Malaysia (100 
and 100%) [16], and in a remote clinic in Uganda (89.5 
and 95.9%) [1], suggesting that malaria LAMP is a use-
ful molecular tool for detection of low-density malaria 
infections, including malaria caused by P. ovale. Of the 
427 clinical samples tested, only 11 resulted in discordant 
results between LAMP and multiplex nested-PCR. All 
these discordant results were false positives compared 
to nPCR results. However, another explanation for these 
results classified as “false-positive” could be that they are 
actually true positive of very-low parasitaemia that were 
undetected by the nPCR reference standard, as has been 
previously reported [16].
Naked-eye readings showed a very good correspond-
ence with the results obtained by turbidimetry. This 
result confirm that LAMP can be used in field settings 
when there is no turbidimeter available, the blood is 
extracted with EDTA anticoagulant and the UV fluores-
cence reading method cannot be used [17].
The limit of detection of P. ovale malaria was deter-
mined between 2 and 0.8 parasites/µl of blood, even 
more sensitive than the results obtained in previous stud-
ies about LoDs for P. ovale, which were performed with 
malachite green-LAMP or with ultraviolet (UV) light as 
reading methods (3 and 10, respectively) [16, 18].
The occurrence of a contamination episode could have 
had an impact in the specificity results, if it had remained 
undetected. Contamination could be due to the semi-
automated nature of the test and the high sensitivity 
of the LAMP technique as has been also documented 
in previous studies [1, 15]. In our case, LAMP reaction 
tubes were tightly closed and never opened after ampli-
fication and read out was done by turbidimetry and with 
the naked eye. Most of the samples were frozen in a dif-
ferent clinical centre, from where the study was com-
pleted, and then the DNA was extracted and frozen in 
the laboratory again until LAMP was done. All these 
manipulations, which are not common in clinical set-
tings, could have increased the chances of contamination.
No false-negative results were detected and this sug-
gests that the Pan malaria LoopAmp® can be used with 
confidence in malaria eradication or control programmes 
where P. ovale is endemic, although the kit does not 
include a set of P. ovale specific primers and further test-
ing as nested specific PCR would be necessary for final 
species identification. However, the specific identification 
of P. ovale in the field would not be crucial, as patients 
could be treated with chloroquine for a non-falciparum 
malaria and the final identification could be made later in 
a reference center.
Conclusion
The Pan primer of the Malaria kit LoopAMP® can detect 
P. ovale at very low-levels and it showed a predictive 
negative value of 100%. This tool can be useful in malaria 
control and elimination programmes and in returned 
travellers from P. ovale endemic areas. Naked eye read-
ings are equivalent to automated turbidimeter readings 
in specimens obtained with EDTA. The relative simplic-
ity of the LAMP procedure and the low infrastructure 
costs open a range of opportunities by bringing molecu-
lar-level parasite detection and capacity of using malaria 
LAMP in field settings [1, 17].
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